Mycoplasma Testing Market Insights Size Share Growth Trends Forecast to 2032
Creators
Description
The global mycoplasma testing market is projected to grow from $972.3 million in 2025 to $1.39 billion by 2032, with a 5.3% CAGR. North America dominates with a 49.02% market share, driven by research activities and R&D investments.
Key highlights:
- Mycoplasma contamination affects 15-35% of continuous cell cultures globally
- Reagents & kits segment leads the market due to high usage in research labs
- PCR-based testing methods hold the largest share due to high sensitivity
- Biopharmaceutical companies are the primary end-users
- COVID-19 positively impacted the market through increased vaccine development testing
Market constraints include high testing costs and a shortage of trained professionals, particularly affecting adoption in emerging markets.
Recent developments show industry consolidation, with SD Biosensor acquiring Meridian Bioscience in January 2023, and significant investments like Pfizer's $100 million research partnership with Flagship Pioneering in July 2023.
Report-
Fortune Business Insights - Mycoplasma Testing Market Size, Share | Growth Report [2032]
https://www.fortunebusinessinsights.com/mycoplasma-testing-market-108687
Files
Mycoplasma Testing Market Size & Share.pdf
Files
(423.4 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:6c5e78ebaf0a38e64e02ae530cc52d0a
|
423.4 kB | Preview Download |